Development of nanocrystal formulation of mebendazole with improved dissolution and pharmacokinetic behaviors

被引：0
|
作者：
Naofumi Hashimoto [1 ]
Kayo Yuminoki [1 ]
Haruka Takeuchi [1 ]
Chiaki Okada [1 ]
机构：
[1] Setsunan University
来源：
AsianJournalofPharmaceuticalSciences | 2016年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R943 [制剂学];
学科分类号：
100602 ; 100702 ;
摘要：
Nanosizing by wet beads milling is a method to improve the solubility of poorly water soluble compounds [1,2]. Mebendazole(MBZ) is a well-known anthelmintic drug in wide clinical use.There were some reports that MBZ had the anticancer effect in preclinical study. However, the bioavailability of MEB is low(<10%) due to the poor solubility in water (0.5μg/mL). The present study aimed to develop the nanocrystal formula-
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [31] Development of Langmuir-Schaeffer Cellulose Nanocrystal Monolayers and Their Interfacial Behaviors
    Habibi, Youssef
    Hoeger, Ingrid
    Kelley, Stephen S.
    Rojas, Orlando J.
    LANGMUIR, 2010, 26 (02) : 990 - 1001
  • [32] Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements
    Solymosi, Tamas
    Otvos, Zsolt
    Angi, Reka
    Ordasi, Betti
    Jordan, Tamas
    Semsey, Sandor
    Molnar, Laszlo
    Ranky, Soma
    Filipcsei, Genoveva
    Heltovics, Gabor
    Glavinas, Hristos
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 532 (01) : 427 - 434
  • [33] Development and Pharmacokinetic Evaluation of a Curcumin Co-solvent Formulation
    John, Mathew K.
    Xie, Huan
    Bell, Edward C.
    Liang, Dong
    ANTICANCER RESEARCH, 2013, 33 (10) : 4285 - 4291
  • [34] Bioavailability and pharmacokinetic studies in the development of an oral formulation of stobadine dipalmitate
    Bauerová, K
    Bohov, P
    Durisová, M
    Bezek, S
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (07): : 499 - 503
  • [35] Expediting the formulation development process with the aid of automated dissolution in analytical research and development
    Sadowitz, JP
    JOURNAL OF AUTOMATED METHODS & MANAGEMENT IN CHEMISTRY, 2001, 23 (06): : 173 - 177
  • [36] Glass dissolution and delamination in formulation development: Implications for neutral pH product development
    Ricci, Margaret S.
    Hair, Alison
    Thirumangalathu, Renuka
    Dharmavaram, Vasu
    Piedmonte, Deirdre
    Latypov, Ramil
    Lau, Hollis
    Bjorklund, Jessica
    Callahan, William
    Purtell, Judy
    Abel, Jeffrey
    Li, Gary
    Fujimori, Kiyoshi
    Torraca, Gianni
    Jing, Wendy
    Wen, Zai-Qing
    Nashed-Samuel, Yasser
    Ratnaswamy, Gayathri
    Swift, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [37] Design and Development of Solid SMEDDS and Liquisolid Formulations of Lovastatin, for Improved Drug Dissolution and In vivo Effects-a Pharmacokinetic and Pharmacodynamic Assessment
    Suram, Dinesh
    Veerabrahma, Kishan
    AAPS PHARMSCITECH, 2022, 23 (05)
  • [38] Canagliflozin loaded SMEDDS: formulation optimization for improved solubility, permeability and pharmacokinetic performance
    Singh D.
    Tiwary A.K.
    Bedi N.
    Journal of Pharmaceutical Investigation, 2019, 49 (1) : 67 - 85
  • [39] In vitro/in vivo characterization of nanocrystalline formulation of tranilast with improved dissolution and hepatoprotective properties
    Onoue, Satomi
    Yamamoto, Kiyoshi
    Kawabata, Yohei
    Yamada, Shizuo
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 952 - 957
  • [40] A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption
    Hong, JY
    Kim, JK
    Song, YK
    Park, JS
    Kim, CK
    JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) : 332 - 338
12345